Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aurora Kinases as Therapeutic Targets in Head and Neck Cancer. | Cancer J | 2022 | 36165728 | PubTator, text mining | PubMed |
| Systematic multi-level analysis of an organelle proteome reveals new peroxisomal functions. | Mol Syst Biol | 2022 | 36164978 | PubTator, text mining | PubMed |
| Human Plasma Proteome During Normal Pregnancy. | J Proteome Res | 2022 | 36154181 | PubTator, text mining | PubMed |
| Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics. | Int J Mol Sci | 2022 | 36142502 | PubTator, text mining | PubMed |
| Proteomic Approaches in the Study of Placenta of Pregnancy Complicated by Gestational Diabetes Mellitus. | Biomedicines | 2022 | 36140373 | PubTator, text mining | PubMed |
| Low Concentrations of Oxidized Phospholipids Increase Stress Tolerance of Endothelial Cells. | Antioxidants (Basel) | 2022 | 36139816 | PubTator, text mining | PubMed |
| Assessment of a Large-Scale Unbiased Malignant Pleural Effusion Proteomics Study of a Real-Life Cohort. | Cancers (Basel) | 2022 | 36139528 | PubTator, text mining | PubMed |
| Disturbed Cardiac Metabolism Triggers Atrial Arrhythmogenesis in Diabetes Mellitus: Energy Substrate Alternate as a Potential Therapeutic Intervention. | Cells | 2022 | 36139490 | PubTator, text mining | PubMed |
| The Patent Ductus Arteriosus in Extremely Preterm Neonates Is More than a Hemodynamic Challenge: New Molecular Insights. | Biomolecules | 2022 | 36139018 | PubTator, text mining | PubMed |
| Are active efflux transporters contributing to infant drug exposure via breastmilk? A longitudinal study. | Basic Clin Pharmacol Toxicol | 2022 | 36130042 | PubTator, text mining | PubMed |
| Characterization of differentially expressed and lipid metabolism-related lncRNA-mRNA interaction networks during the growth of liver tissue through rabbit models. | Front Vet Sci | 2022 | 36118359 | PubTator, text mining | PubMed |
| Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets. | Transl Oncol | 2022 | 36113343 | PubTator, text mining | PubMed |
| Murine blastocysts generated by in vitro fertilization show increased Warburg metabolism and altered lactate production. | Elife | 2022 | 36107481 | PubTator, text mining | PubMed |
| Proteomic and functional characterization of intra-tumor heterogeneity in human endometrial cancer. | Cell Rep Med | 2022 | 36103879 | PubTator, text mining | PubMed |
| A shift in lung macrophage composition is associated with COVID-19 severity and recovery. | Sci Transl Med | 2022 | 36103512 | PubTator, text mining | PubMed |
| MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma. | Aging (Albany NY) | 2022 | 36098680 | PubTator, text mining | PubMed |
| Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma. | Front Immunol | 2022 | 36091049 | PubTator, text mining | PubMed |
| Identify metabolism-related genes IDO1, ALDH2, NCOA2, SLC7A5, SLC3A2, LDHB, and HPRT1 as potential prognostic markers and correlate with immune infiltrates in head and neck squamous cell carcinoma. | Front Immunol | 2022 | 36090994 | PubTator, text mining | PubMed |
| Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions. | Molecules | 2022 | 36080280 | PubTator, text mining | PubMed |
| MYCN and Metabolic Reprogramming in Neuroblastoma. | Cancers (Basel) | 2022 | 36077650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=36